View in EDS

Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin.

Saved in:
Bibliographic Details
Title: Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin.
Authors: Jeyarajan S; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. jeyaraja@umich.edu.; Biomedical Research Core Facilities, Transgenic Animal Model Core, University of Michigan, Ann Arbor, MI, USA. jeyaraja@umich.edu., Ranjith S; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India., Anbarasu A; Swamy Vivekananda Medical College Hospital and Research Institute, Tiruchengode, 637205, Tamil Nadu, India., Kandasamy I; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India., Chidambaram P; Department of Biochemistry, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India., Kumarasamy A; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. anbumbt@bdu.ac.in.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2026 Jul 22; Vol. 43 (9). Date of Electronic Publication: 2026 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42484926
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jeyarajan+S%22">Jeyarajan S</searchLink>; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. jeyaraja@umich.edu.; Biomedical Research Core Facilities, Transgenic Animal Model Core, University of Michigan, Ann Arbor, MI, USA. jeyaraja@umich.edu.<br /><searchLink fieldCode="AU" term="%22Ranjith+S%22">Ranjith S</searchLink>; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Anbarasu+A%22">Anbarasu A</searchLink>; Swamy Vivekananda Medical College Hospital and Research Institute, Tiruchengode, 637205, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Kandasamy+I%22">Kandasamy I</searchLink>; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Chidambaram+P%22">Chidambaram P</searchLink>; Department of Biochemistry, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Kumarasamy+A%22">Kumarasamy A</searchLink>; Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. anbumbt@bdu.ac.in.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2026 Jul 22; Vol. 43 (9). <i>Date of Electronic Publication: </i>2026 Jul 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42484926
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12032-026-03344-0
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeyarajan S
      – PersonEntity:
          Name:
            NameFull: Ranjith S
      – PersonEntity:
          Name:
            NameFull: Anbarasu A
      – PersonEntity:
          Name:
            NameFull: Kandasamy I
      – PersonEntity:
          Name:
            NameFull: Chidambaram P
      – PersonEntity:
          Name:
            NameFull: Kumarasamy A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 07
              Text: 2026 Jul 22
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1559-131X
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Medical oncology (Northwood, London, England)
              Type: main
ResultId 1